E

Making a difference in aggressive lymphomas

Round-up of key highlights relating to CAR-T cell therapies, CELMoDs and super-enhancer activity in DLBCL

June 22, 2021
E

New developments in hematologic malignancies to make your head turn

A look at two under the radar early developments in lymphomas which might have a shot at approval

June 17, 2021
E

A look at 6 key developments in advanced hematologic malignancies

A look at 6 IO products in the Heme space and what to watch out for.

June 10, 2021
E

Pillars of future strategies in tackling aggressive lymphomas

Some intriguing new developments in DLBCL to watch out for

August 20, 2020